Drawing for BIMAX

USPTO serial 76206557

BIMAX

Reviewed by CopyMark Law Group

Status 605
Filing date
Status date
Registration date
—
Examiner
EULIN, INGRID C
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BIMAX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

L. S. VAN LANDINGHAM, III

L S VAN LANDINGHAM III12921 BRIDGER DRGERMANTOWN, MD 20874UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
036administering a compensation plan and benefit program for employees and independent distributors who engage in the retail sale and distribution through direct sales, network marketing and internet marketing of health care products, cosmetics, nutritional supplements, health foods, publications and related productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 2, 2002ABN5ABANDONMENT - AFTER PUBLICATION—
Sep 24, 2001ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Aug 21, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 1, 2001NPUBNOTICE OF PUBLICATION—
May 19, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
May 17, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance